BIOCORP, a French company specializing in the development and manufacturing of innovative medical and drug delivery devices, has won the Best Exhibitor Innovation Award presented by Pharmapack Europe 2016 for Easylog, Biocorp’s smart sensor. The ceremony was held on February, 11th at Paris Expo.
The awards are organized alongside the Pharmapack Europe conference and exhibition each year from its inception in 1997 onwards, and reward the best innovations in the pharmaceutical industry every year.
Biocorp’s smart sensor Easylog has received an award in the category Best Exhibitor Innovation for “customization and user-friendliness” acknowledged for being an intuitive real time monitoring tool for patients and health care professionals.
EasyLog, a Smart Sensor for Drug Delivery Systems
Easylog is a smart sensor that converts all insulin delivery devices, reusable as well as disposable, into internet-connected and communicating devices. Easylog mobile application provides users with reminders for drug delivery, alerts in case of double injection, real-time access to patients’ historical data and personalized logbook.
Easylog is an innovative solution that meets the challenges of personalized medicine and is a crucial tool to ensure the highest quality of treatment against chronic diseases, improving the patient’s comfort and providing relevant information for treatment follow-up to healthcare professionals.
Back in 2015, Biocorp had already been awarded by Pharmapack for its Datapen, a connected injector pen.
“We are very honored to receive this new Award presented by Pharmapack Europe. Following Datapen in 2015, it is the turn of our Easylog smart sensor to be in the public eye. Easylog is a unique solution that contributes to the increase of the compliance rates, which are still very low among patients suffering from chronic diseases. Our contribution in this field aims to improve the patient’s comfort and data reliability for all stake holders. We are extremely proud to receive the Pharmapack Award which highlights once again our innovations and the major progress they bring,” said Jacques Gardette, Biocorp’s CEO and founder.
Click here for more information.